Recombinant interleukin-18
Term · Oncology and biomedicine · MLC-T-ONC-016436
A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine interleukin-18 (IL-18). Produced primarily by macrophages, IL-18 induces the production of interferon-gamma (IFN-gamma), and enhances the activity of natural killer (NK) and cytotoxic T lymphocytes (CTL). As a potential immunotherapeutic agent, IL-18 displays antitumor effects in vitro and in animal models.
| Identifier | MLC-T-ONC-016436 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | IL-18 |
| Synonyms | interferon-gamma-inducing factor; IFN-gamma-inducing factor |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016436",
"term": "Recombinant interleukin-18",
"field": "Oncology and biomedicine",
"definition": "A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine interleukin-18 (IL-18). Produced primarily by macrophages, IL-18 induces the production of interferon-gamma (IFN-gamma), and enhances the activity of natural killer (NK) and cytotoxic T lymphocytes (CTL). As a potential immunotherapeutic agent, IL-18 displays antitumor effects in vitro and in animal models.",
"abbreviation": "IL-18",
"synonyms": [
"interferon-gamma-inducing factor",
"IFN-gamma-inducing factor"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/recombinant-interleukin-18/"
}
Record 14,182 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.